Pfizer, Gilead, GSK to lead infectious diseases market
Despite a 63.8 per cent decline in forecast sales for Covid-19 drugs in 2023, infectious disease drug sales are expected to maintain momentum going
Pfizer set to supply Paxlovid Covid pills to Africa
US drugmaker Pfizer is set to supply Africa’s top health body with its Covid antiviral pill Paxlovid…reports Asian Lite News Paperwork for the deal
